AMYLIN PHARMACEUTICALS INC: cashflow_investing

Value{"amount": -138055000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2012-01-01 – 2012-03-31
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000881464-12-000006 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:02.716993+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/cashflow-investing/2012-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/e6cdff3a-5034-4d56-a201-abc7d9ee5151

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies